[Restenosis inside the stent: treatment and prevention].
Arablinskiĭ
A V
AV
Zakharova
O V
OV
Kononov
A V
AV
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D017225:Atherectomy, Coronary; D002986:Clinical Trials as Topic; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000532:radiotherapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D017239:Paclitaxel / Q000008:administration & dosage; D010919:Placebos; D016032:Randomized Controlled Trials as Topic; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects / Q000592:standards; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D010919:Placebos; D017239:Paclitaxel; D020123:Sirolimus